Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.2B | 14.2B | 12.2B | 11.9B |
Cost of revenue | 7.8B | 6.1B | 5.5B | 5.4B |
Gross profit | 9.4B | 8.0B | 6.8B | 6.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.4B | 3.3B | 3.2B | 3.1B |
Operating income | 3.1B | 1.8B | 708.2M | 651.4M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 564M | 578M | 526.1M | 491.9M |
Other income expense | — | — | — | — |
Pretax income | 3.1B | 1.3B | 228.1M | 184.6M |
Tax provision | 784.7M | 400.7M | 50.9M | 62.5M |
Net income | 2.3B | 929.4M | 199.5M | 126.8M |
Basic EPS | — | 1.7 | 0.4 | 0.2 |
Diluted EPS | — | 1.7 | 0.4 | 0.2 |
Basic average shares | — | 539.8M | 536.2M | 543.9M |
Diluted average shares | — | 539.8M | 536.2M | 543.9M |
EBITDA | 4.8B | 2.9B | 1.8B | 1.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | 9M | -6.4M | -1.1M | -1.7M |
Preferred stock dividends | 0 | 0 | 0 | 0 |